Before going to medical school, Dr. Searle attended Brigham Young University, majoring in Psychology with a pre-medicine emphasis. His medical training was at the University of Texas Health Science Center in San Antonio, TX. While completing his Medical Doctor Degree, he also participated in research with the orthopedic department examining the calcification processes of synovial and connective tissues. Dr. Searle then went to Phoenix, Arizona and completed his residency in Family Medicine at Banner Good Samaritan Hospital.

Dr. Searle began pharmaceutical research at Dedicated Phase One in Phoenix. He was Medical Director and Principal Investigator, and also on the company’s Board of Directors, for the first two years of the company’s existence and Dr. Searle helped it grow to be one of the premiere early-phase, patient-population sites in the Southwest. Study areas included Diabetes, Lupus, Alzheimer’s disease, Rheumatoid Arthritis, Multiple Sclerosis, Bipolar disorder and Healthy/Normal populations.

After a short time back in clinical medicine, Dr. Searle returned to early-phase research at Comprehensive Clinical Development in Tacoma, Washington. As Principal Investigator, his studies included First-In-Human trials as well as Oncology, Dermatology, Chronic Hepatitis C and Vaccine trials. He also certified and became licensed as an Authorized User of Radioactivity for the State of Washington. With this, he was the principal or sub-investigator for numerous trials examining the ADME (Absorption, Distribution, Metabolism and Excretion) and Pharmacokinetics of C 14 -labelled compounds in healthy/normal and Oncology patient populations.

He completed his first two years of medical school at the Universidad Autonoma de Guadalajara; where he acquired a solid foundation in clinical medicine and fluency in Spanish. He continued his education in Puerto Rico, and ultimately obtained his Medical Degree from Ponce School of Medicine.

After medical school, Dr. Sabet returned to the United States for continued training in Phoenix, Arizona. There he completed a dual residency in Internal Medicine and Pediatrics from Maricopa Medical Center in affiliation with Phoenix Children’s Hospital. He went on to become Chief Resident in Internal Medicine at Maricopa Medical Center and soon thereafter obtained his board certifications in both Internal Medicine and Pediatrics.

Following residency Dr. Sabet embarked on a series of travel medicine assignments. He spent a year working as a consultant physician in New Zealand; after which he returned to work as an Internal Medicine hospitalist in several areas across the western United States. Ultimately, he settled in Salt Lake City and after more than ten years of practicing and teaching clinical medicine, he found his way back to research.

Dr. Sabet joined ICON as a Sub-Investigator in September of 2015. His broad clinical experience has been well employed on trials across multiple disciplines including: pain/therapeutics, anesthesiology, immunology, lipid/metabolism, viral hepatitis, Alzheimer’s disease, and depression. His research experience includes First-In-Human, HAL, BA, BE, VRH, and PK/PD trials in addition to multicenter phase II and III studies. He has ascended through the research ranks and currently serves as Principal investigator on several early and late phase clinical trials.

Dr. Johnston continued to the University of Oklahoma, with residency study in Family Medicine. His final year he served as Chief Resident for the program and participated in education and training of students and residents. Dr. Johnston served as an adjunct professor with the University of Oklahoma teaching medical students in Family Medicine. Completing a master’s degree in Medical Management from Tulane University, with an emphasis on Population Health and Medical Economics allowed Dr. Johnston to serve on multiple hospital administrative boards.
• The medical leadership board for the Cherokee Nation Health System
• The Inaugural Board of Directors for the Tulsa County Health Improvement Organization
• Pharmacy Therapeutic Board for an insurance company
• The Medical Department Chairman at a Regional Hospital
• Rural Health Liaison for the Oklahoma Healthy Heart Project
o reaching out to rural physicians as an educator and colleague while collecting data for research to help improve population health outcomes.

Dr. Johnston joined ICON as a full-time Clinical Research Physician in September of 2017. Serving as a Sub-Investigator and Principal Investigator on more than 40 studies across multiple disciplines. Studies include: pain/therapeutics, Alzheimer’s disease, depression, immunology, oncology, liver disease, and lipid metabolism. These trials involve first-in-human testing, BA/BE studies, PK/PD trials, drug-drug Interaction, HAL, and multicenter phase II and phase III outpatient studies.